Zhang C - Search Results

1

Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis.

Wu P, Zhang C, Tang X, Li D, Zhang G, Zi X, Liu J, Yin E, Zhao J, Wang P, Wang L, Li R, Wu Y, Sun N, He J. Wu P, et al. Among authors: zhang c, zhang g. Mol Cancer. 2024 Feb 12;23(1):31. doi: 10.1186/s12943-023-01915-7. Mol Cancer. 2024. PMID: 38347558 Free PMC article.

2

Specific clinical and immune features of CD68 in glioma via 1,024 samples.

Wang L, Zhang C, Zhang Z, Han B, Shen Z, Li L, Liu S, Zhao X, Ye F, Zhang Y. Wang L, et al. Among authors: zhang c, zhang z, zhang y. Cancer Manag Res. 2018 Nov 27;10:6409-6419. doi: 10.2147/CMAR.S183293. eCollection 2018. Cancer Manag Res. 2018. PMID: 30568502 Free PMC article.

3

Screening common signaling pathways associated with drug resistance in non-small cell lung cancer via gene expression profile analysis.

Sun T, Zhao Q, Zhang C, Cao L, Song M, Maimela NR, Liu S, Wang J, Gao Q, Qin G, Wang L, Zhang Y. Sun T, et al. Among authors: zhang c, zhang y. Cancer Med. 2019 Jun;8(6):3059-3071. doi: 10.1002/cam4.2190. Epub 2019 Apr 25. Cancer Med. 2019. PMID: 31025554 Free PMC article.

4

The TGFβ-Induced Long Non-coding RNA TBULC Promotes the Invasion and Migration of Non-small Cell Lung Cancer Cells and Indicates Poor Prognosis.

Zheng S, Lu Z, Liu C, Wang X, Jin R, Mao S, Huang J, Lei Y, Zhang C, Sun N, He J. Zheng S, et al. Among authors: zhang c. Front Oncol. 2019 Dec 10;9:1340. doi: 10.3389/fonc.2019.01340. eCollection 2019. Front Oncol. 2019. PMID: 31921623 Free PMC article.

5

Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.

Zhang C, Zhang Z, Zhang G, Zhang Z, Luo Y, Wang F, Wang S, Che Y, Zeng Q, Sun N, He J. Zhang C, et al. Among authors: zhang g, zhang z. Cancer Lett. 2020 Jun 1;479:31-41. doi: 10.1016/j.canlet.2020.03.016. Epub 2020 Mar 19. Cancer Lett. 2020. PMID: 32201203

6

Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer.

Lei Y, Sun N, Zhang G, Liu C, Lu Z, Huang J, Zhang C, Zang R, Che Y, Mao S, Fang L, Wang X, Zheng S, He J. Lei Y, et al. Among authors: zhang c, zhang g. Clin Transl Med. 2020 Jul;10(3):e128. doi: 10.1002/ctm2.128. Epub 2020 Jul 13. Clin Transl Med. 2020. PMID: 32659050 Free PMC article.

7

Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.

Che Y, Luo Z, Zhang C, Sun N, Gao S, He J. Che Y, et al. Among authors: zhang c. Int Immunopharmacol. 2020 Oct;87:106802. doi: 10.1016/j.intimp.2020.106802. Epub 2020 Jul 31. Int Immunopharmacol. 2020. PMID: 32745903 Free article.

8

Response to comment on 'Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma'.

Sun N, Zhang C, He J. Sun N, et al. Among authors: zhang c. Cancer Lett. 2020 Dec 1;494:5-6. doi: 10.1016/j.canlet.2020.07.033. Epub 2020 Aug 5. Cancer Lett. 2020. PMID: 32763273 No abstract available.

9

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma.

Zhang C, Zhang G, Sun N, Zhang Z, Zhang Z, Luo Y, Che Y, Xue Q, He J. Zhang C, et al. Among authors: zhang g, zhang z. EBioMedicine. 2020 Sep;59:102959. doi: 10.1016/j.ebiom.2020.102959. Epub 2020 Aug 25. EBioMedicine. 2020. PMID: 32853987 Free PMC article.

10

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma.

Zhang C, Zhang G, Sun N, Zhang Z, Xue L, Zhang Z, Yang H, Luo Y, Zheng X, Zhang Y, Yuan Y, Lei R, Yang Z, Zheng B, Wang L, Che Y, Wang F, Wang S, Gao S, Xue Q, Zhang Y, He J. Zhang C, et al. Among authors: zhang g, zhang z, zhang y. Signal Transduct Target Ther. 2020 Sep 4;5(1):182. doi: 10.1038/s41392-020-00221-8. Signal Transduct Target Ther. 2020. PMID: 32883946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,768 results

Search Page